Verma S - Search Results

1

Permission to prescribe: do cardiologists need permission to prescribe diabetes medications that afford cardiovascular benefit?

Sharma A, Aziz H, Verma S, Abramson BL, Choi R, Chua GL, Connelly KA, Honos G, Mancini GBJ, Ramer SA, Swiggum E, Teoh H, Zieroth S, Leiter LA. Sharma A, et al. Among authors: verma s. Curr Opin Cardiol. 2021 Sep 1;36(5):672-681. doi: 10.1097/HCO.0000000000000892. Curr Opin Cardiol. 2021. PMID: 34173772 Review.

2

Perindopril in diabetes: perspective from the EUROPA substudy, PERSUADE.

Verma S, Leiter LA, Lonn EM, Strauss MH. Verma S, et al. Eur Heart J. 2005 Jul;26(14):1347-9. doi: 10.1093/eurheartj/ehi308. Epub 2005 May 4. Eur Heart J. 2005. PMID: 15872030 No abstract available.

3

Canadian Cardiovascular Society Consensus Conference: peripheral arterial disease - executive summary.

Abramson BL, Huckell V, Anand S, Forbes T, Gupta A, Harris K, Junaid A, Lindsay T, McAlister F, Roussin A, Saw J, Teo KK, Turpie AG, Verma S; Canadian Cardiovascular Society. Abramson BL, et al. Among authors: verma s. Can J Cardiol. 2005 Oct;21(12):997-1006. Can J Cardiol. 2005. PMID: 16234879

4

Adiponectin and cardiovascular disease: state of the art?

Szmitko PE, Teoh H, Stewart DJ, Verma S. Szmitko PE, et al. Among authors: verma s. Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1655-63. doi: 10.1152/ajpheart.01072.2006. Epub 2006 Dec 1. Am J Physiol Heart Circ Physiol. 2007. PMID: 17142348 Free article. Review.

5

Vascular dysfunction: a Janus face of visfatin in diabetes?

Teoh H, Lovren F, Verma S. Teoh H, et al. Among authors: verma s. Metabolism. 2007 Apr;56(4):459-61. doi: 10.1016/j.metabol.2006.12.002. Metabolism. 2007. PMID: 17379000 No abstract available.

6

Does C-reactive protein predict saphenous vein graft patency?

Teoh H, Quan A, Verma S. Teoh H, et al. Among authors: verma s. J Thorac Cardiovasc Surg. 2007 Aug;134(2):277-9. doi: 10.1016/j.jtcvs.2007.03.025. J Thorac Cardiovasc Surg. 2007. PMID: 17662761 Free article. No abstract available.

7

ACE inhibitors: back to prime time?

Gupta M, Verma S, Mancini GB. Gupta M, et al. Among authors: verma s. Heart. 2007 Sep;93(9):1015-6. doi: 10.1136/hrt.2006.108100. Heart. 2007. PMID: 17699166 Free PMC article.

8

C-reactive protein, metabolic syndrome, and end organ damage.

Teoh H, Verma S. Teoh H, et al. Among authors: verma s. Metabolism. 2007 Dec;56(12):1620-2. doi: 10.1016/j.metabol.2007.07.002. Metabolism. 2007. PMID: 17998011 No abstract available.

9

Impaired endothelial function in C-reactive protein overexpressing mice.

Teoh H, Quan A, Lovren F, Wang G, Tirgari S, Szmitko PE, Szalai AJ, Ward ME, Verma S. Teoh H, et al. Among authors: verma s. Atherosclerosis. 2008 Dec;201(2):318-25. doi: 10.1016/j.atherosclerosis.2008.02.034. Epub 2008 Mar 20. Atherosclerosis. 2008. PMID: 18433756

10

Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis.

Lovren F, Pan Y, Quan A, Teoh H, Wang G, Shukla PC, Levitt KS, Oudit GY, Al-Omran M, Stewart DJ, Slutsky AS, Peterson MD, Backx PH, Penninger JM, Verma S. Lovren F, et al. Among authors: verma s. Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H1377-84. doi: 10.1152/ajpheart.00331.2008. Epub 2008 Jul 25. Am J Physiol Heart Circ Physiol. 2008. PMID: 18660448 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,374 results

Search Page